Jesús Calahorra

Instituto de Investigación Biosanitaria de Granada — Spain

Medicine · Health Sciences

10h-index304citations18works5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antioxidant Activity and Oxidative Stress(3), Immunotherapy and Immune Responses(3), Cancer, Hypoxia, and Metabolism(3), Nanoplatforms for cancer theranostics(3), Cholesterol and Lipid Metabolism(3)

Publications18 total

Phenotypic AI-based design of cell-specific small molecule cytotoxics
2025Open Access
The effect of Fe3O4 biosynthesized through the green synthesis of Silybum marianum and HA in the targeted delivery of 5-Fluorouracil to HCT116 cell line
DARU Journal of Pharmaceutical Sciences·2025· 3 citedOpen Access
Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer
International Journal of Biological Sciences·2025· 2 citedOpen Access
Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy
Pharmaceutics·2025· 2 citedOpen Access
Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy
Molecular Cancer·2024· 15 citedOpen Access
Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells
Biomedicine & Pharmacotherapy·2024· 11 citedOpen Access
Tyrosol: Repercussion of the Lack of a Hydroxyl-Group in the Response of MCF-7 Cells to Hypoxia
Journal of Medicinal Food·2023· 3 cited
TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression
International Journal of Biological Sciences·2022· 20 citedOpen Access
Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer
Pharmaceutics·2022· 12 citedOpen Access
Impact of hydroxytyrosol on stroke: tracking therapy response on neuroinflammation and cerebrovascular parameters using PET-MR imaging and on functional outcomes
Theranostics·2021· 36 citedOpen Access
Crosstalk between hydroxytyrosol, a major olive oil phenol, and HIF-1 in MCF-7 breast cancer cells
Scientific Reports·2020· 42 citedOpen Access
Mitotic entry upon Topo II catalytic inhibition is controlled by Chk1 and Plk1
FEBS Journal·2020· 4 citedOpen Access
Hydroxytyrosol, the Major Phenolic Compound of Olive Oil, as an Acute Therapeutic Strategy after Ischemic Stroke
Nutrients·2019· 42 citedOpen Access
Tyrosol, a simple phenol from EVOO, targets multiple pathogenic mechanisms of neurodegeneration in a C. elegans model of Parkinson's disease
Neurobiology of Aging·2019· 55 cited
MCPH1 is essential for cellular adaptation to the G <sub>2</sub> ‐phase decatenation checkpoint
The FASEB Journal·2019· 8 citedOpen Access
Hypoxia modulates the antioxidant effect of hydroxytyrosol in MCF-7 breast cancer cells
PLoS ONE·2018· 28 citedOpen Access
Hydroxytyrosol decreases the oxidative and nitrosative stress levels and promotes angiogenesis through HIF-1 independent mechanisms in renal hypoxic cells
Food & Function·2015· 16 cited
Soluble guanylate cyclase β1-subunit expression is increased in mononuclear cells from patients with erectile dysfunction
International Journal of Impotence Research·2006· 5 cited

Frequent Co-authors

Eva Siles(7), Sergio Granados‐Principal(7), Araceli López-Tejada(6), Carmen Griñán‐Lisón(6), José L. Blaya-Cánovas(6), Esther Martínez‐Lara(5), Juan Antonio Marchal(5), Ana Cañuelo(4), Isabel Blancas(4), Violeta Delgado-Almenta(4), Francisca E. Cara(3), José M. Granadino‐Roldán(2), Marı́a Angeles Peinado(2), Maximilian Wiesmann(2), Amanda J. Kiliaan(2), Adrián González-González(2), Alba Navarro-Ocón(2), César L. Ramírez-Tortosa(2), Rosario M. Sánchez‐Martín(2), María del Carmen Guerrero Arroyo(2)